Naslund Medical AB is a privately held medical products company focused on the improved management and care of patients receiving radiation therapy. As the pioneer and leader in developing new technology for fiducial markers, Naslund Medical AB markets Gold Anchor worldwide. Gold Anchor enables quicker and more effective radiation therapy treatment with increased patient safety. Naslund Medical AB is based in Sweden with subsidiaries in the U.S. and France and with contracted distributors on a global level. The Gold Anchor has been invented and developed by Ingemar Naslund, M.D, Associate Professor, working as head of the Division of Radiation Therapy, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden for 20 years. Dr. Naslund was also part of the first publication on the SBRT-technique that he invented with his colleagues Dr. Henrik Blomgren and Associate Professor Ingemar Lax. This technique has now spread all over the world and is becoming standard of care for some tumours. Top benefits with Gold Anchor: - Minimally invasive - Great visibility - Instant stability Our customers have found that Gold Anchor enables them to: - Reduce complication rates from marker implantation - Shorten lead times - Treat more patients - Easily fuse CT and MR images - Reduce CT artifacts - Reduce dose perturbation in proton therapy The unique marker design provides superior tissue attachment. The marker is also visible on MRI (T1 & T2). All this makes Gold Anchor ideal for SBRT. We seek to help improve radiotherapy worldwide by developing, manufacturing, marketing and selling our product Gold Anchor.